Palumbo, F.E.; Duminuco, A.; Longo, L.; Vitale, D.C.; Maugeri, C.; Brancati, S.; Parisi, M.S.; Palumbo, G.A.; Romano, G.L.; Drago, F.;
et al. Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax. J. Clin. Med. 2025, 14, 5007.
https://doi.org/10.3390/jcm14145007
AMA Style
Palumbo FE, Duminuco A, Longo L, Vitale DC, Maugeri C, Brancati S, Parisi MS, Palumbo GA, Romano GL, Drago F,
et al. Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax. Journal of Clinical Medicine. 2025; 14(14):5007.
https://doi.org/10.3390/jcm14145007
Chicago/Turabian Style
Palumbo, Fanny Erika, Andrea Duminuco, Laura Longo, Daniela Cristina Vitale, Cinzia Maugeri, Serena Brancati, Marina Silvia Parisi, Giuseppe Alberto Palumbo, Giovanni Luca Romano, Filippo Drago,
and et al. 2025. "Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax" Journal of Clinical Medicine 14, no. 14: 5007.
https://doi.org/10.3390/jcm14145007
APA Style
Palumbo, F. E., Duminuco, A., Longo, L., Vitale, D. C., Maugeri, C., Brancati, S., Parisi, M. S., Palumbo, G. A., Romano, G. L., Drago, F., Di Raimondo, F., Gozzo, L., & Vetro, C.
(2025). Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax. Journal of Clinical Medicine, 14(14), 5007.
https://doi.org/10.3390/jcm14145007
